The Journal of Urology
Volume 184, Issue 3 , Pages 833-841, September 2010

Contemporary Management of Renal Tumors With Venous Tumor Thrombus

Institute of Urologic Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California

Received 10 August 2009 published online 20 July 2010.

Purpose

Renal cell carcinoma with intravenous tumor thrombus remains one of the most intriguing and challenging topics in urological oncology. With better understanding of the biology of intravascular tumor invasion and improvements in overall survival, the surgical and medical treatment of these patients is being completely redefined.

Materials and Methods

We performed a MEDLINE® search for relevant articles on renal cell carcinoma with intravenous tumor thrombus.

Results

We describe the staging systems, prognostic factors and surgical techniques involved in the management of renal cell carcinoma with intravenous tumor thrombus. We also review long-term survival of local, advanced and metastatic renal cell carcinoma with tumor thrombus invasion. Finally, we propose a clinical algorithm for the treatment of patients with renal cell carcinoma invading the venous system.

Conclusions

Management of a kidney cancer tumor invading the venous system should now consider the primary biology and natural behavior of a given tumor in that specific patient rather than only focusing on the level and extent of venous invasion. Treatment must be individualized for every patient based on performance status, tumor biology and risk of surgery.

Key Words: carcinoma, renal cell, kidney neoplasms, neoplasm invasiveness

Abbreviations and Acronyms: CPBP, cardiopulmonary bypass procedure, CT, computerized tomography, DHCA, deep hypothermia circulatory arrest, DSS, disease specific survival, ECOG, Eastern Cooperative Oncology Group, IVC, inferior vena cava, IVTT, intravenous tumor thrombus, MDCT, multidetector CT, MRI, magnetic resonance imaging, RCC, renal cell carcinoma, RV, renal vein, TKI, tyrosine kinase inhibitors, VVBP, venovenous bypass procedure

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Nothing to disclose.

 Supported in part by the McLaughlin and the Conseil des Médecins Dentistes et Pharmaciens fellowship scholarships from Laval University, the Québec Urologist Association, and the Canadian Institutes of Health Research fellowship scholarships (FP).

 Editor's Note: This article is the first of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 1234 and 1235.

PII: S0022-5347(10)03506-8

doi:10.1016/j.juro.2010.04.071

The Journal of Urology
Volume 184, Issue 3 , Pages 833-841, September 2010